Over 12 months, Attovia Therapeutics, Inc. saw more buying than selling from its insiders — purchases of about $72.9 million against sales of $9 million.
Biggest single buyer: FHMLS XI, L.P., 10% Owner, with roughly $10 million.
Quarter by quarter: Last full quarter: net buying by insiders. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | WALSH COLIN | Director | Sell | 200 | $22.10 | $4K | SEC |
| Aug 28, 2026 | WALSH COLIN | Director | Buy | 85,000 | $21.00 | $1.8M | SEC |
| Aug 28, 2026 | WALSH COLIN | Director | Sell | 988 | $22.03 | $22K | SEC |
| Aug 28, 2026 | WALSH COLIN | Director | Sell | 447 | $21.87 | $10K | SEC |
| Aug 28, 2026 | WALSH COLIN | Director | Sell | 1,332 | $22.03 | $29K | SEC |
| Aug 28, 2026 | WALSH COLIN | Director | Sell | 200 | $22.05 | $4K | SEC |
| Aug 28, 2026 | WALSH COLIN | Director | Sell | 1,556 | $22.06 | $34K | SEC |
| Aug 28, 2026 | WALSH COLIN | Director | Sell | 3,402 | $22.02 | $75K | SEC |
| Aug 28, 2026 | WALSH COLIN | Director | Buy | 500,000 | $17.00 | $8.5M | SEC |
| Aug 28, 2026 | WALSH COLIN | Director | Sell | 480 | $21.55 | $10K | SEC |
| Aug 28, 2026 | WALSH COLIN | Director | Sell | 100 | $22.11 | $2K | SEC |
| Aug 28, 2026 | WALSH COLIN | Director | Sell | 753 | $21.97 | $17K | SEC |
| Aug 28, 2026 | WALSH COLIN | Director | Sell | 672 | $22.02 | $15K | SEC |
| Aug 28, 2026 | WALSH COLIN | Director | Sell | 6,970 | $22.03 | $154K | SEC |
| Aug 28, 2026 | WALSH COLIN | Director | Sell | 400 | $22.02 | $9K | SEC |
In the last 12 months Attovia Therapeutics, Inc. insiders made open-market purchases worth about $72.9 million and sales worth about $9 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in ATTO was filed on 2026-08-28.
No congressional trades in ATTO were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).